Literature DB >> 31362039

Adaptation and application of a two-plasmid inducible CRISPR-Cas9 system in Clostridium beijerinckii.

Mamou Diallo1, Rémi Hocq2, Florent Collas3, Gwladys Chartier2, François Wasels2, Hani Surya Wijaya3, Marc W T Werten3, Emil J H Wolbert3, Servé W M Kengen4, John van der Oost4, Nicolas Lopes Ferreira5, Ana M López-Contreras3.   

Abstract

Recent developments in CRISPR technologies have opened new possibilities for improving genome editing tools dedicated to the Clostridium genus. In this study we adapted a two-plasmid tool based on this technology to enable scarless modification of the genome of two reference strains of Clostridium beijerinckii producing an Acetone/Butanol/Ethanol (ABE) or an Isopropanol/Butanol/Ethanol (IBE) mix of solvents. In the NCIMB 8052 ABE-producing strain, inactivation of the SpoIIE sporulation factor encoding gene resulted in sporulation-deficient mutants, and this phenotype was reverted by complementing the mutant strain with a functional spoIIE gene. Furthermore, the fungal cellulase-encoding celA gene was inserted into the C. beijerinckii NCIMB 8052 chromosome, resulting in mutants with endoglucanase activity. A similar two-plasmid approach was next used to edit the genome of the natural IBE-producing strain C. beijerinckii DSM 6423, which has never been genetically engineered before. Firstly, the catB gene conferring thiamphenicol resistance was deleted to make this strain compatible with our dual-plasmid editing system. As a proof of concept, our dual-plasmid system was then used in C. beijerinckii DSM 6423 ΔcatB to remove the endogenous pNF2 plasmid, which led to a sharp increase of transformation efficiencies.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CRISPR-Cas9; Clostridium beijerinckii; Genome editing; Nuclease

Mesh:

Substances:

Year:  2019        PMID: 31362039     DOI: 10.1016/j.ymeth.2019.07.022

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  5 in total

1.  Streamlined CRISPR genome engineering in wild-type bacteria using SIBR-Cas.

Authors:  Constantinos Patinios; Sjoerd C A Creutzburg; Adini Q Arifah; Belén Adiego-Pérez; Evans A Gyimah; Colin J Ingham; Servé W M Kengen; John van der Oost; Raymond H J Staals
Journal:  Nucleic Acids Res       Date:  2021-11-08       Impact factor: 16.971

2.  CRISPR/Cas9-Mediated Genome Editing for Pseudomonas fulva, a Novel Pseudomonas Species with Clinical, Animal, and Plant-Associated Isolates.

Authors:  Nan Zhang; Jintao He; Abrar Muhammad; Yongqi Shao
Journal:  Int J Mol Sci       Date:  2022-05-13       Impact factor: 6.208

Review 3.  Sporulation in solventogenic and acetogenic clostridia.

Authors:  Mamou Diallo; Servé W M Kengen; Ana M López-Contreras
Journal:  Appl Microbiol Biotechnol       Date:  2021-04-26       Impact factor: 4.813

4.  Improved CRISPR/Cas9 Tools for the Rapid Metabolic Engineering of Clostridium acetobutylicum.

Authors:  Tom Wilding-Steele; Quentin Ramette; Paul Jacottin; Philippe Soucaille
Journal:  Int J Mol Sci       Date:  2021-04-02       Impact factor: 5.923

5.  CRISPR/Cas12a Mediated Genome Editing To Introduce Amino Acid Substitutions into the Mechanosensitive Channel MscCG of Corynebacterium glutamicum.

Authors:  Karin Krumbach; Christiane Katharina Sonntag; Lothar Eggeling; Jan Marienhagen
Journal:  ACS Synth Biol       Date:  2019-12-11       Impact factor: 5.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.